Matches in Wikidata for { <http://www.wikidata.org/entity/Q94403907> ?p ?o ?g. }
- Q94403907 description "2017 nî lūn-bûn" @default.
- Q94403907 description "2017 թվականի նոյեմբերի 6-ին հրատարակված գիտական հոդված" @default.
- Q94403907 description "2017年の論文" @default.
- Q94403907 description "2017年学术文章" @default.
- Q94403907 description "2017年学术文章" @default.
- Q94403907 description "2017年学术文章" @default.
- Q94403907 description "2017年学术文章" @default.
- Q94403907 description "2017年学术文章" @default.
- Q94403907 description "2017年学术文章" @default.
- Q94403907 description "2017年學術文章" @default.
- Q94403907 description "2017年學術文章" @default.
- Q94403907 description "2017年學術文章" @default.
- Q94403907 description "2017年學術文章" @default.
- Q94403907 description "2017年學術文章" @default.
- Q94403907 description "2017년 논문" @default.
- Q94403907 description "article científic" @default.
- Q94403907 description "article scientific" @default.
- Q94403907 description "article scientifique" @default.
- Q94403907 description "articol științific" @default.
- Q94403907 description "articolo scientifico" @default.
- Q94403907 description "artigo científico" @default.
- Q94403907 description "artigo científico" @default.
- Q94403907 description "artigo científico" @default.
- Q94403907 description "artikel ilmiah" @default.
- Q94403907 description "artikull shkencor" @default.
- Q94403907 description "artikulong pang-agham" @default.
- Q94403907 description "artykuł naukowy" @default.
- Q94403907 description "artículo científico publicado en 2017" @default.
- Q94403907 description "artículu científicu" @default.
- Q94403907 description "bilimsel makale" @default.
- Q94403907 description "bài báo khoa học" @default.
- Q94403907 description "naučni članak" @default.
- Q94403907 description "scienca artikolo" @default.
- Q94403907 description "scientific article published on 6 November 2017" @default.
- Q94403907 description "scientific article published on 6 November 2017" @default.
- Q94403907 description "scientific article published on 6 November 2017" @default.
- Q94403907 description "teaduslik artikkel" @default.
- Q94403907 description "tieteellinen artikkeli" @default.
- Q94403907 description "tudományos cikk" @default.
- Q94403907 description "vedecký článok" @default.
- Q94403907 description "vetenskaplig artikel" @default.
- Q94403907 description "videnskabelig artikel udgivet 6. november 2017" @default.
- Q94403907 description "vitenskapelig artikkel" @default.
- Q94403907 description "vitskapeleg artikkel" @default.
- Q94403907 description "vědecký článek" @default.
- Q94403907 description "wetenschappelijk artikel" @default.
- Q94403907 description "wissenschaftlicher Artikel" @default.
- Q94403907 description "επιστημονικό άρθρο" @default.
- Q94403907 description "мақолаи илмӣ" @default.
- Q94403907 description "наукова стаття, опублікована в листопаді 2017" @default.
- Q94403907 description "научна статия" @default.
- Q94403907 description "научная статья" @default.
- Q94403907 description "научни чланак" @default.
- Q94403907 description "научни чланак" @default.
- Q94403907 description "מאמר מדעי" @default.
- Q94403907 description "مقالة علمية نشرت في 6 نوفمبر 2017" @default.
- Q94403907 description "৬ নভেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q94403907 description "บทความทางวิทยาศาสตร์" @default.
- Q94403907 description "სამეცნიერო სტატია" @default.
- Q94403907 name "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 name "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 type Item @default.
- Q94403907 label "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 label "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 prefLabel "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 prefLabel "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 P1433 Q94403907-51B04425-B003-43CB-8997-CF4760CA4BCA @default.
- Q94403907 P1476 Q94403907-DA82A6F8-72CC-4E81-A164-49B316D2ED5F @default.
- Q94403907 P2093 Q94403907-04B708C7-A5B7-4B8D-BC6C-92CB6291868B @default.
- Q94403907 P2093 Q94403907-27A93543-CB32-462E-B463-F6B0FE59E941 @default.
- Q94403907 P2093 Q94403907-3369847A-45A6-4358-816C-75A637671641 @default.
- Q94403907 P2093 Q94403907-4E42CE20-25E4-413B-8B00-60D631E7A5B6 @default.
- Q94403907 P2093 Q94403907-6B41D345-3CAE-46B1-A503-22D021865DC7 @default.
- Q94403907 P2093 Q94403907-97416B7F-A5F9-4B3A-B3A5-115B0A1DB1C3 @default.
- Q94403907 P2093 Q94403907-BBFFC47D-5361-47D8-899A-DBFE9DDE131A @default.
- Q94403907 P2093 Q94403907-D7273B8D-1B1F-49FA-89AE-DEF7FD588DD0 @default.
- Q94403907 P2093 Q94403907-F7E01BF7-E8DF-4084-B845-2AACAAC136EA @default.
- Q94403907 P2093 Q94403907-FA6ACFF5-8A26-4297-AEEF-6D19A0A15D6C @default.
- Q94403907 P2093 Q94403907-FB7C9FF3-3225-4133-A8E8-E0E4A7DD72F0 @default.
- Q94403907 P304 Q94403907-6F6EEAAE-23B0-4BA8-A439-1000BB7A2516 @default.
- Q94403907 P31 Q94403907-5C8976F0-1B46-4A1F-9973-317BF46FC8FA @default.
- Q94403907 P356 Q94403907-9BBD5866-B502-47AC-B1C4-3165DCFE38BA @default.
- Q94403907 P433 Q94403907-524108FC-5F53-4319-8D5D-8720F02D7A10 @default.
- Q94403907 P478 Q94403907-30858A64-6A4E-494C-91CA-09D59E6DB397 @default.
- Q94403907 P50 Q94403907-C377A08B-629C-4806-A557-D0FCC3CB8C8D @default.
- Q94403907 P50 Q94403907-CAEC5012-785E-49E6-9156-B2569B8399C9 @default.
- Q94403907 P50 Q94403907-E9E16411-61A4-477D-94BD-7D0D06CE498C @default.
- Q94403907 P577 Q94403907-14325714-2D34-4D70-8031-A7965B6F717F @default.
- Q94403907 P921 Q94403907-3F7CEF0A-BBB6-4F4A-BCE6-C197F0E189E1 @default.
- Q94403907 P921 Q94403907-F85103E7-83B1-4925-85A8-C1732ED3B405 @default.
- Q94403907 P932 Q94403907-0972CD88-0D8C-41E2-B1F2-2208F9882AC2 @default.
- Q94403907 P356 NOX168.822 @default.
- Q94403907 P1433 Q15724471 @default.
- Q94403907 P1476 "QLIF-12. HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)" @default.
- Q94403907 P2093 "Ahmed Idbaih" @default.
- Q94403907 P2093 "Andrew Bottomley" @default.
- Q94403907 P2093 "Corneel Coens" @default.
- Q94403907 P2093 "Joanne Lewis" @default.
- Q94403907 P2093 "Martin J B Taphoorn" @default.
- Q94403907 P2093 "Martin van den Bent" @default.